Stock Price
14.56
Daily Change
-0.22 -1.49%
Monthly
-1.09%
Yearly
37.62%
Q2 Forecast
14.12

Amarin reported $0.14 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amarin USD 0.14 0.06 Dec/2025
AstraZeneca USD 2.58 0.46 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
DBV Technologies USD -0.24 1.31 Sep/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 1.99 0.04 Mar/2026